Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VTR-297 by Vanda Pharmaceuticals for Onychomycosis (Tinea Unguium): Likelihood of Approval
VTR-297 is under clinical development by Vanda Pharmaceuticals and currently in Phase I for Onychomycosis (Tinea Unguium). According to GlobalData,...